Dissecting the Structure–Activity Relationship of Galectin–Ligand Interactions
AbstractGalectins are β-galactoside-binding proteins. As carbohydrate-binding proteins, they participate in intracellular trafficking, cell adhesion, and cell–cell signaling. Accumulating evidence indicates that they play a pivotal role in numerous physiological and pathological activities, such as the regulation on cancer progression, inflammation, immune response, and bacterial and viral infections. Galectins have drawn much attention as targets for therapeutic interventions. Several molecules have been developed as galectin inhibitors. In particular, TD139, a thiodigalactoside derivative, is currently examined in clinical trials for the treatment of idiopathic pulmonary fibrosis. Herein, we provide an in-depth review on the development of galectin inhibitors, aiming at the dissection of the structure–activity relationship to demonstrate how inhibitors interact with galectin(s). We especially integrate the structural information established by X-ray crystallography with several biophysical methods to offer, not only in-depth understanding at the molecular level, but also insights to tackle the existing challenges. View Full-Text
Share & Cite This Article
Chan, Y.-C.; Lin, H.-Y.; Tu, Z.; Kuo, Y.-H.; Hsu, S.-T.D.; Lin, C.-H. Dissecting the Structure–Activity Relationship of Galectin–Ligand Interactions. Int. J. Mol. Sci. 2018, 19, 392.
Chan Y-C, Lin H-Y, Tu Z, Kuo Y-H, Hsu S-TD, Lin C-H. Dissecting the Structure–Activity Relationship of Galectin–Ligand Interactions. International Journal of Molecular Sciences. 2018; 19(2):392.Chicago/Turabian Style
Chan, Yi-Chen; Lin, Hsien-Ya; Tu, Zhijay; Kuo, Yen-Hsi; Hsu, Shang-Te D.; Lin, Chun-Hung. 2018. "Dissecting the Structure–Activity Relationship of Galectin–Ligand Interactions." Int. J. Mol. Sci. 19, no. 2: 392.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.